
Epitherapeutics
Developing novel innovative cancer drugs based on epigenetics.
Enterprise value
$65m
Recent deals
loading funding rounds…
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by Epitherapeutics
Edit
exited

ACQUISITION by Kite Pharma Dec 2022